Published in J Immunol on December 15, 1993
Separate endocytic pathways regulate IL-5 receptor internalization and signaling. J Leukoc Biol (2008) 1.01
Upregulation by glucocorticoids of responses to eosinopoietic cytokines in bone-marrow from normal and allergic mice. Br J Pharmacol (2000) 1.00
IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis. J Immunol (2016) 0.77
Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med (1982) 9.49
Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells (1999) 3.69
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med (1988) 3.50
Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene (1989) 3.00
Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF. J Immunol (1980) 2.95
Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med (1988) 2.71
CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis (1992) 2.38
Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature (1986) 2.28
Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol Cell Biol (2000) 2.14
Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med (1989) 2.12
Atomic-level observation of disclination dipoles in mechanically milled, nanocrystalline Fe. Science (2002) 2.07
Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucleic Acids Res (1986) 2.04
Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med (1991) 1.89
Molecular cloning and expression of the murine interleukin-5 receptor. EMBO J (1990) 1.85
Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med (1994) 1.83
A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction. Mol Cell Biol (1994) 1.77
T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. Immunol Rev (1988) 1.76
Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins. Immunity (2000) 1.74
Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J Immunol Methods (1990) 1.74
Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line. J Immunol (1981) 1.73
BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12). J Immunol (1985) 1.72
Purification and physicochemical characterization of murine T cell replacing factor (TRF). J Immunol (1985) 1.67
Analysis of Th1 and Th2 cells in murine gut-associated tissues. Frequencies of CD4+ and CD8+ T cells that secrete IFN-gamma and IL-5. J Immunol (1990) 1.67
Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Immunity (1995) 1.56
Differential signaling by lymphocyte antigen receptors. Annu Rev Immunol (1997) 1.54
High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocr J (2001) 1.53
Antigen-induced T cell-replacing factor (TRF). I. Functional characterization of a TRF-producing helper T cell subset and genetic studies on TRF production. J Immunol (1980) 1.51
Soluble factors involved in B cell differentiation: identification of two distinct T cell-replacing factors (TRF). J Immunol (1983) 1.46
CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis (1993) 1.43
Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity (1996) 1.40
T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells. Proc Natl Acad Sci U S A (1987) 1.40
Spontaneous disappearance of a middle cranial fossa arachnoid cyst after suppurative meningitis. Surg Neurol (1998) 1.39
Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1987) 1.39
Distribution of IL-5 receptor-positive B cells. Expression of IL-5 receptor on Ly-1(CD5)+ B cells. J Immunol (1990) 1.36
Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors. Proc Natl Acad Sci U S A (1985) 1.34
Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication. J Exp Med (1988) 1.33
Molecular cloning and expression of the human interleukin 5 receptor. J Exp Med (1992) 1.31
IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med (1994) 1.30
Reaginic antibody formation in the mouse. VI. Suppression of IgE and IgG antibody responses to ovalbumin following the administration of high dose urea-denatured antigen. Cell Immunol (1975) 1.27
The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice. Immunology (1991) 1.26
Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines. Proc Natl Acad Sci U S A (1989) 1.22
Renal leiomyoma: an immunohistochemical, ultrastructural and comparative genomic hybridization study. Histol Histopathol (2007) 1.21
Reaginic antibody formation in the mouse. VII. Induction of suppressor T cells for IgE and IgG antibody responses. J Immunol (1976) 1.20
T cells from eosinophilic patients produce interleukin-5 with interleukin-2 stimulation. Blood (1989) 1.20
Reconstitution of the functional receptors for murine and human interleukin 5. J Exp Med (1993) 1.19
Characterization of the murine interleukin 5 receptor by using a monoclonal antibody. Int Immunol (1990) 1.18
Detection and characterization of the flagellar master operon in the four Shigella subgroups. J Bacteriol (1996) 1.17
Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol (1999) 1.17
Incidence of intracranial aneurysm associated with pituitary adenoma. Neurosurg Rev (1997) 1.16
Cloning and characterization of the region III flagellar operons of the four Shigella subgroups: genetic defects that cause loss of flagella of Shigella boydii and Shigella sonnei. J Bacteriol (1997) 1.16
Interleukin-5 and its receptor system: implications in the immune system and inflammation. Adv Immunol (1994) 1.14
Mapping of V beta 11+ helper T cell epitopes on mycobacterial antigen in mouse primed with Mycobacterium tuberculosis. Int Immunol (1997) 1.11
Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells. Immunology (1989) 1.10
Establishment of IL-5-dependent early B cell lines by long-term bone marrow cultures. Growth Factors (1989) 1.08
Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues. J Immunol (1999) 1.08
Protective roles of eosinophils in Nippostrongylus brasiliensis infection. Int Arch Allergy Immunol (1997) 1.08
Symptomatic Rathke's cleft cyst coexisting with central diabetes insipidus and hypophysitis: case report. Endocr J (1999) 1.08
IL-5 predominant in bronchoalveolar lavage fluid and peripheral blood in a patient with acute eosinophilic pneumonia. Intern Med (1995) 1.07
Antigenic structure and phase variation in Bordetella pertussis. Jpn J Microbiol (1969) 1.07
Conversion of the Salmonella phase 1 flagellin gene fliC to the phase 2 gene fljB on the Escherichia coli K-12 chromosome. J Bacteriol (1993) 1.06
Distinct mechanisms of alpha 5beta 1 integrin activation by Ha-Ras and R-Ras. J Biol Chem (2000) 1.05
Role of carbohydrate moiety of IL-5. Effect of tunicamycin on the glycosylation of IL-5 and the biologic activity of deglycosylated IL-5. J Immunol (1990) 1.04
In vivo changes of hemopoietic progenitors and the expression of the interleukin 5 gene in eosinophilic mice infected with Toxocara canis. Exp Hematol (1990) 1.04
IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. Int Immunol (1993) 1.04
An IFN-gamma-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus. Int Immunol (1994) 1.03
Mechanisms of eosinophilia in BALB/c-nu/+ and congenitally athymic BALB/c-nu/nu mice infected with Toxocara canis. Immunology (1995) 1.03
Interleukin 5 and interleukin 3 induce serine and tyrosine phosphorylations of several cellular proteins in an interleukin 5-dependent cell line. Biochem Biophys Res Commun (1990) 1.00
A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5. Proc Natl Acad Sci U S A (1997) 1.00
Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity. Cancer (1999) 1.00
Identification of an I-J+ antigen-presenting cell required for third order suppressor cell activation. J Exp Med (1983) 1.00
T cell replacing factor/interleukin 5 induces not only B-cell growth and differentiation, but also increased expression of interleukin 2 receptor on activated B-cells. Immunol Lett (1987) 0.99
Large inversion in Escherichia coli K-12 1485IN between inversely oriented IS3 elements near lac and cdd. Genetics (1991) 0.99